Infection of human T-lymphotropic virus type-1 (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): Chronological studies of early events
References (32)
- et al.
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome
Lancet
(1984) - et al.
Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line
Virology
(1981) - et al.
Nucleotide sequence of the AIDS virus, LAV
Cell
(1985) - et al.
Adsorption, penetration, and uncoating of murine leukemia virus studied by using its reverse transcriptase
J. Virol.
(1979) - et al.
Transmission of HTLV-III infection from human plasma to chimpanzees: An animal model for AIDS
Science (Washington, D. C.)
(1984) - et al.
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
Science (Washington, D. C.)
(1983) - et al.
Infectivity dissociated from transforming activity in a human retrovirus, adult T-cell leukemia virus
Gann
(1982) - et al.
Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line
Science (Washington, D. C.)
(1983) - et al.
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Nature (London)
(1984) - et al.
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
Science (Washington, D. C.)
(1984)
Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I
Science (Washington, D. C.)
Infection of HTLV-III/LAV in HTLV-I carrying cells, MT-2 and MT-4 and application in a plaqueassay
Science (Washington, D. C)
Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line
Jpn. J. Cancer Res. (Gann)
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS
Science (Washington, D. C.)
Identification of T cell lymphoma tumor antigens on human T cell lines
Amer. J. Hematol.
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes
Science (Washington, D. C.)
Cited by (79)
HIV-1 Vif adaptation to human APOBEC3H haplotypes
2013, Cell Host and MicrobeCitation Excerpt :Cells were maintained at 37°C in a humidified atmosphere of 5% CO2. TZM-bl cells, MT2 T cells, and MT4 T cells were provided by the AIDS Research and Reference Reagent Program (Haertle et al., 1988; Harada et al., 1985; Wei et al., 2002). The adherent cell lines HEK293T and TZM-bl were maintained in Dulbecco’s high-glucose modified Eagle’s medium, supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 50 units/ml penicillin, and 50 μg/ml streptomycin.
Novel strategy for anti-HIV-1 action: Selective cytotoxic effect of N-myristoyltransferase inhibitor on HIV-1-infected cells
2002, FEBS LettersCitation Excerpt :The reagents used in the study were obtained from the following sources: the RPMI-1640 medium and Dulbecco’s modified Eagle’s medium (DMEM) were from Nissui Seiyaku Co. (Tokyo, Japan); N-myristoyl serinal bisulfite, O-myristoyl serinal bisulfite, N-acetyl-O-palmitoyl serinal diethylacetal, and N-acetyl-O-myristoyl serinal diethylacetal were gifts from Dr. S. Ikeda (Torii and Co., Ltd., Tokyo, Japan). A human T-cell line, CEM, and a chronically HIV-1-infected T-cell line, CEM/LAV-1, were maintained as previously described [19]. A human colon adenocarcinoma cell line, COLO320DM, was cultured at 37°C in DMEM supplemented with 5% fetal calf serum (100 IU/ml penicillin and 100 μg/ml streptomycin) in 5% CO2.
Cyclic Zinc-Dithiocarbamate-S,S'-Dioxide blocks CXCR4-mediated HIV-1 infection
2000, Biochemical and Biophysical Research Communications